RaQualia Pharma Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | RaQualia Pharma Inc.

RaQualia Pharma Inc. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Lazard Asset Management LLC

39,200

0.19%

06/30/2018

GO ETF Solutions LLP

800

02/28/2018

View Profile

Address	Daiwa Meieki Building, 8/F Nagoya Aichi 450 Japan
Employees	-
Website	http://www.raqualia.co.jp
Updated	09/14/2018
RaQualia Pharma, Inc. engages in a research and development of pharmaceuticals. Its medicines focus on pain, gastrointestinal, auto-immune diseases, inflammation, cancer, and Alzheimer's. Its products include Anidulafungin, Dalbavancin, Ziprasidone, 5-HT4 Partial Agonist, and 5-HT2B Antagonist.